DoD Kidney Cancer, Academy of Kidney Cancer Investigators – Leadership Award
ID: 355138Type: Posted
Overview

Buyer

Dept. of the Army -- USAMRAA (DOD-AMRAA)

Eligible Applicants

Unrestricted

Funding Category

Science and Technology and other Research and Development

Funding Instrument

Cooperative Agreement

Opportunity Category

Discretionary

Cost Sharing or Matching Requirement

Yes

Original Source

https://grants.gov/search-results-detail/355138
Timeline
    Description

    The Department of the Army, through the US Army Medical Research and Materiel Command (USAMRAA), is offering the FY24 Kidney Cancer Academy of Kidney Cancer Investigators – Leadership Award, aimed at fostering innovative kidney cancer research and leadership development among early-career investigators. This funding opportunity seeks applications for an Academy Director and Deputy Director to lead the Academy, with a focus on enhancing research capacity, collaboration, and mentorship in kidney cancer studies. The initiative is critical for advancing understanding of kidney cancer biology and therapeutic strategies, ultimately improving patient care. The total estimated funding for this program is $2.4 million, with individual awards capped at $1.5 million for a performance period of up to five years. Key deadlines include a pre-application submission by August 29, 2024, and a full application due by September 19, 2024. For further inquiries, applicants can contact the CDMRP Help Desk at help@eBRAP.org or by phone at 301-682-5507.

    Point(s) of Contact
    help@eBRAP.org
    Files
    Title
    Posted
    HT942524KCRPAKCILA_GG_Final.pdf
    The Department of Defense (DOD) is announcing the FY24 Kidney Cancer Academy of Kidney Cancer Investigators – Leadership Award under the Defense Health Program. This funding opportunity aims to support innovative kidney cancer research with a focus on leadership development for early-career investigators. Total appropriations for this program since its inception in 2017 amount to $235 million, with an allocation of $50 million for FY24. Applications must contribute to understanding kidney cancer biology, therapeutic strategies, and improving patient care. Key dates include a pre-application deadline of August 29, 2024, and a full application deadline on September 19, 2024. Eligible applicants include independent kidney cancer researchers with an established record in mentorship. Each proposal must specify a minimum of three pilot projects conducted collaboratively among Academy leaders and scholars. Primary funding will not support clinical trials but encourages collaborations across military and civilian sectors to advance kidney cancer research effectively. The anticipated budget for this award is capped at $1,500,000 for a maximum performance period of five years. This initiative underlines the commitment to fostering a new generation of kidney cancer researchers to significantly impact the field.
    Similar Opportunities
    DoD Kidney Cancer, Academy of Kidney Cancer Investigators - Early-Career Scholar Award
    Active
    Dept. of the Army -- USAMRAA
    The Department of the Army, through the US Army Medical Research and Materiel Command (USAMRAA), is offering the FY24 Academy of Kidney Cancer Investigators - Early-Career Scholar Award, aimed at fostering innovative kidney cancer research by supporting early-career scholars. This program encourages applicants to develop research projects that address critical areas in kidney cancer biology, novel therapies, and healthcare disparities, while providing intensive mentoring and networking opportunities within a collaborative Academy environment. With an estimated total program funding of $2.32 million, the initiative anticipates awarding approximately two grants, with applications due by October 15, 2024, following a pre-application letter of intent due by September 24, 2024. For further inquiries, applicants can contact the CDMRP Help Desk at help@eBRAP.org or call 301-682-5507.
    DoD Kidney Cancer, Idea Development Award
    Active
    Dept. of the Army -- USAMRAA
    The Department of the Army, through the US Army Medical Research and Materiel Command (USAMRAA), is offering the Fiscal Year 2024 Kidney Cancer Research Program's Idea Development Award, aimed at advancing innovative and high-impact kidney cancer research. This grant opportunity encourages projects that align with strategic goals such as enhancing understanding of kidney cancer biology, developing novel therapies, and addressing healthcare disparities, with a focus on benefiting active-duty military personnel, veterans, and the general public. The total estimated funding for this program is approximately $18.56 million, with around 13 awards anticipated, and key deadlines include a pre-application due by September 24, 2024, and a full application deadline of October 15, 2024. For further inquiries, applicants can contact the CDMRP Help Desk at help@eBRAP.org or call 301-682-5507.
    DoD Kidney Cancer, Clinical Trial Award
    Active
    Dept. of the Army -- USAMRAA
    The Department of the Army, through the US Army Medical Research and Development Command (USAMRAA), is offering a funding opportunity for the Fiscal Year 2024 Kidney Cancer Research Program (KCRP) Clinical Trial Award, aimed at supporting innovative clinical trials that can significantly impact kidney cancer treatment and management. The program encourages proposals that range from preliminary proof-of-concept trials to large-scale studies, emphasizing the need for robust preliminary data, access to suitable patient populations, and necessary materials for the trials. With an estimated total program funding of $6.4 million and the expectation of awarding approximately two grants, interested applicants must submit a pre-application letter of intent by September 24, 2024, and a complete application by October 15, 2024. For further inquiries, applicants can contact the CDMRP Help Desk at help@eBRAP.org or call 301-682-5507.
    DoD Kidney Cancer, Translational Research Partnership Award
    Active
    Dept. of the Army -- USAMRAA
    The Department of the Army, through the US Army Medical Research and Materiel Command (USAMRAA), is offering the FY24 Kidney Cancer Translational Research Partnership Award, a federal grant aimed at fostering collaborative research partnerships between clinicians and research scientists to advance kidney cancer treatment and care. This opportunity encourages the development of translational research projects that address significant problems in kidney cancer, requiring partnerships that include one clinician and one research scientist who contribute equally to the research design and execution. With an estimated total program funding of $7.68 million, the program anticipates awarding approximately six grants, each with a maximum budget of $800,000 over a three-year period. Interested applicants must submit a pre-application letter of intent by September 24, 2024, followed by a full application due by October 15, 2024. For further inquiries, applicants can contact the CDMRP Help Desk at help@eBRAP.org or call 301-682-5507.
    DoD Peer Reviewed Cancer, Virtual Cancer Center Director Award
    Active
    Dept. of the Army -- USAMRAA
    The Department of the Army, through the US Army Medical Research and Development Command (USAMRAA), is inviting applications for the FY24 Peer Reviewed Cancer Virtual Cancer Center Director Award (VCCDA), aimed at enhancing collaborative cancer research relevant to military health. This grant opportunity seeks experienced cancer researchers to lead a virtual cancer center that will support early-career investigators, fostering mentorship and innovative approaches to cancer research through convergent science. With an estimated total program funding of approximately $2.8 million and a budget cap of $1.75 million for individual applications, interested applicants must submit a pre-application by July 24, 2024, and a full application by October 15, 2024. For further inquiries, applicants can contact the CDMRP Help Desk at help@eBRAP.org or call 301-682-5507.
    DoD Peer Reviewed Cancer, Impact Award
    Active
    Dept. of the Army -- USAMRAA
    The Department of the Army, through the US Army Medical Research and Materiel Command (USAMRAA), is offering the FY24 Peer Reviewed Cancer Impact Award, aimed at funding high-impact cancer research that benefits Service Members, Veterans, and their families. This grant opportunity seeks to support mature research projects that address critical cancer issues, with a focus on translational or clinical research that demonstrates the potential for significant near-term impact on patient outcomes. With an estimated total program funding of $16 million and the expectation of awarding approximately 10 grants, applicants must submit a pre-application by June 21, 2024, followed by a full application due by September 26, 2024. For further inquiries, interested parties can contact the CDMRP Help Desk at help@eBRAP.org or call 301-682-5507.
    DoD Rare Cancers, Idea Development Award
    Active
    Dept. of the Army -- USAMRAA
    The Department of the Army, through the Congressionally Directed Medical Research Programs (CDMRP), is offering the Fiscal Year 2024 Rare Cancers Idea Development Award to support innovative research aimed at advancing the understanding and treatment of rare cancers. This grant opportunity encourages proposals that focus on understanding molecular pathways, developing tumor-specific models, or identifying novel therapies, with an emphasis on research that can significantly impact patient outcomes. The total funding available for this program is approximately $17.5 million, with individual awards capped at $350,000 over a three-year period, and applications are due in two stages: a pre-application by June 17, 2024, and a full application by September 23, 2024. For further inquiries, applicants can contact the CDMRP Help Desk at help@eBRAP.org or by phone at 301-682-5507.
    DoD Peer Reviewed Cancer, Advancing Cancer Care Through Clinical Trials Award
    Active
    Dept. of the Army -- USAMRAA
    The Department of the Army, through the US Army Medical Research and Development Command (USAMRAA), is offering a grant opportunity titled "DoD Peer Reviewed Cancer, Advancing Cancer Care Through Clinical Trials Award" for Fiscal Year 2024. This funding initiative aims to support the rapid implementation of clinical trials that have the potential to significantly impact cancer treatment and management, particularly for military personnel and their families, addressing specific topic areas related to military health. With an estimated total program funding of $24 million and the expectation of awarding up to five grants, eligible applicants can submit proposals that demonstrate the feasibility and relevance of their clinical trials, with a maximum award amount of $3 million. Interested parties must submit their applications by October 15, 2024, and can reach out to the CDMRP Help Desk at help@eBRAP.org for further assistance.
    DoD Rare Cancers, Resource Community Development Award
    Active
    Dept. of the Army -- USAMRAA
    The Department of the Army, through the U.S. Army Medical Research Acquisition Activity, is offering the FY24 Rare Cancers Resource and Community Development Award to support research initiatives aimed at improving outcomes for individuals with rare cancers. This grant opportunity seeks to develop clinical or preclinical datasets and research resources that address significant gaps in rare cancer research, emphasizing collaboration among researchers, patients, and clinicians, with a mandatory inclusion of patient advocates in the project planning and implementation phases. With an estimated total funding of $6.4 million available for up to five awards, each project can receive a maximum of $800,000 over a four-year period. Interested applicants must submit a pre-application followed by a full application, with the submission deadline set for September 23, 2024. For further inquiries, applicants can contact the CDMRP Help Desk at help@eBRAP.org or call 301-682-5507.
    DoD Peer Reviewed Cancer, Idea Award
    Active
    Dept. of the Army -- USAMRAA
    The Department of the Army, through the US Army Medical Research and Development Command (USAMRAA), is offering the FY24 Peer Reviewed Cancer Idea Award, a federal grant aimed at supporting innovative and high-risk cancer research relevant to military personnel, Veterans, and their families. This grant encourages proposals that challenge existing paradigms and explore new perspectives in cancer research, specifically excluding incremental advancements or ongoing projects. With an estimated total program funding of $16 million and the expectation of awarding approximately 20 grants, each project can receive up to $400,000 over a two-year period. Interested applicants must submit a pre-application by June 21, 2024, with full applications due later for those invited to proceed, and can reach out to the CDMRP Help Desk at help@eBRAP.org for further assistance.